Athena Drug Delivery Solutions Profile
Key Indicators
- Authorised Capital ₹ 50.75 Cr
as on 08-07-2024
- Paid Up Capital ₹ 27.68 Cr
as on 08-07-2024
- Company Age 29 Year,
- Last Filing with ROC 31 Dec 2023
- Open Charges ₹ 26.00 Cr
as on 08-07-2024
- Satisfied Charges ₹ 36.48 Cr
as on 08-07-2024
- Revenue 57.32%
(FY 2022)
- Profit 227.79%
(FY 2022)
- Ebitda 239.77%
(FY 2022)
- Net Worth 24.68%
(FY 2022)
- Total Assets 31.22%
(FY 2022)
About Athena Drug Delivery Solutions
The Corporate was formerly known as Ethypharm Ll Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 50.75 Cr and a paid-up capital of Rs 27.68 Cr.
The company currently has active open charges totaling ₹26.00 Cr. The company has closed loans amounting to ₹36.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Athena Drug Delivery Solutions Private Limited India are Tejas Gawade as COMPANY SECRETARY and Subhash Thalodil as Cfo. Maryline Williams, Alexandre Williams, and Mahendra Chaudhari serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC094546
- Company No.
094546
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1995
- Date of AGM
05 Jun 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Athena Drug Delivery Solutions?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejas Gawade | Company Secretary | 16-Apr-2018 | Current |
Mahendra Chaudhari  | Managing Director | 10-Apr-2018 | Current |
| Subhash Thalodil | CFO | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maryline Williams  | Director | 06-Apr-2017 | Current |
| Alexandre Williams | Whole-Time Director | 08-Mar-2011 | Current |
Financial Performance and Corporate Structure Insights of Athena Drug Delivery Solutions.
Athena Drug Delivery Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 57.32% increase. The company also saw a substantial improvement in profitability, with a 227.79% increase in profit. The company's net worth Soared by an impressive increase of 24.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Athena Drug Delivery Solutions?
In 2022, Athena Drug Delivery Solutions had a promoter holding of 99.66% and a public holding of 0.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2022 | ₹2.00 Cr | Open |
Others Creation Date: 30 May 2022 | ₹3.00 Cr | Open |
Axis Bank Limited Creation Date: 09 Apr 2021 | ₹21.00 Cr | Open |
How Many Employees Work at Athena Drug Delivery Solutions?
Athena Drug Delivery Solutions has a workforce of 178 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Athena Drug Delivery Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Athena Drug Delivery Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
